This NDC is on FDA's drug shortage list (posted Oct 12, 2022)

Reported reason: Shortage of an active ingredient

Product Information

DEXTROAMP-AMPHETAMIN 15 MG TAB is a generic product labeled by Epic Pharma LLC, priced at $0.2370 per EA under NDC 42806034301. Its NADAC has been published 407 times since Nov 7, 2018.

FDA first approved this application on Jun 19, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEA Schedule CII

Strength

3.75; 3.75; 3.75; 3.75 mg/1; mg/1; mg/1; mg/1

Manufacturer

Epic Pharma LLC

NDC

42806034301

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA040444

FDA Approved

6/19/2002

TE Code

AB

On Market Since

8/17/2018

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHETAMIN 15 MG TAB has been published 407 times since Nov 7, 2018, and over the history we have for it it has declined 52.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2370 per EA
All-time high$0.5054 (Mar 13, 2019)
All-time low$0.1838 (Nov 20, 2024)
52-week high$0.2936
52-week low$0.2370
Median price$0.2882
Average price$0.3080
Largest weekly change+39.5% (Feb 22, 2023)
Weeks tracked407
Tracking sinceNov 7, 2018

Price History

1W

-1.1%

1M

-1.1%

3M

-5.3%

6M

-13.3%

1Y

-10.1%

3Y

-18.6%

5Y

-19.9%

All

-52.0%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHETAMIN 15 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 15 MG TAB, manufactured by Epic Pharma LLC, is $0.2370 per EA (NDC 42806034301), effective Aug 19, 2026.

How has the price of DEXTROAMP-AMPHETAMIN 15 MG TAB changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 15 MG TAB has declined 52.0%. It has been tracked across 407 weekly CMS publications since Nov 7, 2018.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 15 MG TAB?

Since Nov 7, 2018, the NADAC for DEXTROAMP-AMPHETAMIN 15 MG TAB has ranged from a low of $0.1838 (Nov 20, 2024) to a high of $0.5054 (Mar 13, 2019), with a median of $0.2882 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 15 MG TAB?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHETAMIN 15 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures DEXTROAMP-AMPHETAMIN 15 MG TAB?

DEXTROAMP-AMPHETAMIN 15 MG TAB (NDC 42806034301) is labeled by Epic Pharma LLC, and CMS classifies it as a generic product.

Is DEXTROAMP-AMPHETAMIN 15 MG TAB in shortage?

Yes — NDC 42806034301 is currently listed in FDA's drug shortage database (posted Oct 12, 2022). Reported reason: Shortage of an active ingredient.